{
  "docId": "019de070-7c63-7128-8a46-f79d73ca634e",
  "docSlug": "e7a5d9b34e946c6ef888782967ccb8f4",
  "documentTitle": "AbCellera | IPO Presentation Deck | 38 slides",
  "authorId": "abcellera",
  "authorName": "AbCellera",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investment_bank",
  "sourceTypeLabel": "Investment bank",
  "presentationDate": "2020-12-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 35,
  "pageCount": 38,
  "prevPage": 34,
  "nextPage": 36,
  "slideType": "appendix",
  "function": "other",
  "density": "dense",
  "nDataPoints": 5,
  "notes": "The slide emphasizes the longevity of their IP, with key patents extending to 2034 and 2040.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de070-7c63-7128-8a46-f79d73ca634e/35",
  "deckHref": "/decks/019de070-7c63-7128-8a46-f79d73ca634e",
  "deckJsonHref": "/decks/019de070-7c63-7128-8a46-f79d73ca634e.json",
  "deckAnchorHref": "/decks/019de070-7c63-7128-8a46-f79d73ca634e#slide-35",
  "components": [
    {
      "bbox": {
        "h": 0.1,
        "w": 0.6,
        "x": 0.12,
        "y": 0.35
      },
      "kind": "list",
      "text": "40+ applications worldwide; 15 patent families; Owned or exclusively licensed",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "16ca0d13-ee49-4aa5-893b-2c20ad4e91eb",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.2,
        "w": 0.15,
        "x": 0.12,
        "y": 0.55
      },
      "kind": "metric",
      "text": "35+ PATENTS",
      "attrs": null,
      "subkind": "big-number",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "9ac0fab8-f915-47fb-8a5a-35b29796a847",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.6,
        "x": 0.3,
        "y": 0.8
      },
      "kind": "paragraph",
      "text": "Foundational claims on high-throughput single-cell secretion assays with application to antibody discovery & clone selection",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "66cc54c6-a85c-4314-a2e5-4a9a78ee46be",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.2,
        "w": 0.6,
        "x": 0.3,
        "y": 0.55
      },
      "kind": "table",
      "text": "Methods for Assaying (2034); Immune Rep Seq (2034); COVID-19 (2040)",
      "attrs": null,
      "subkind": "data",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "8093a51e-1849-41f4-83d1-cfca3f273475",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.65,
        "x": 0.12,
        "y": 0.15
      },
      "kind": "title",
      "text": "GLOBAL INTELLECTUAL PROPERTY PORTFOLIO WITH FOUNDATIONAL PATENTS.",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "410bd4f9-be72-4a95-a3de-cf0b0d58342c",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Credibility Transfer",
      "slug": "credibility-transfer",
      "agent": "Storyteller",
      "layer": "slide",
      "matchId": "c6464224-6310-4a72-b334-905e7952df6a",
      "evidence": "The mention of a global intellectual property portfolio with foundational patents implies credibility.",
      "confidence": 0.6
    }
  ],
  "frameworks": [],
  "arcBeats": [],
  "loops": [
    {
      "to": 38,
      "from": 4,
      "name": "Golden Circle",
      "slug": "11-golden-circle",
      "bestFor": "Visionary leadership, brand positioning, mission statements",
      "matchId": "0790a1a3-4790-4249-807c-1b7d69510973",
      "evidence": "The deck presents a clear 'why' for AbCellera's technology throughout",
      "position": 1,
      "objective": "Why is AbCellera's technology the right solution for antibody discovery?",
      "structure": "The Why (Belief) -> The How (Process) -> The What (Result)",
      "confidence": 0.7,
      "description": "Invert the typical pitch by starting with why you exist, rather than what you do"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}